| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $109.7M | +7.6% | +23.6% |
| Cost of Revenue | $28.1M | +6.3% | +32.6% |
| Gross Profit | $81.6M | +8.0% | +20.7% |
| R&D Expense | $13.9M | +7.5% | +8.6% |
| SG&A Expense | $23.9M | +21.4% | +40.4% |
| Operating Income | $8.1M | +14.6% | +6.2% |
| Pre-tax Income | $12.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $471.6M | +9.7% | +88.8% |
| Accounts Receivable | $90.9M | -2.6% | +13.6% |
| Current Assets | $580.7M | +7.6% | +70.3% |
| Total Assets | $743.5M | +6.2% | +60.6% |
| Current Liabilities | $244.9M | +7.3% | +25.8% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $55.6M | — | — |
| Capital Expenditures | $3.0M | — | — |
| Investing Cash Flow | -$31.2M | — | — |
| Financing Cash Flow | $155.5M | — | — |
| Free Cash Flow | $52.6M | — | — |
| +86.9% |
| +311.7% |
| Income Tax | -$210K | -105.3% | -214.8% |
| Net Income | $13.0M | +382.5% | +396.8% |
| EPS (Basic) | $0.06 | +500.0% | +500.0% |
| EPS (Diluted) | $0.06 | +500.0% | +500.0% |
| $276.7M |
| +7.7% |
| +11.9% |
| Stockholders' Equity | $466.8M | +5.3% | +116.4% |